To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene KAT2BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
303 supporting clones for gene KAT2B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
U57317 Liver KAT2B.a 1 to 3014 1 to 3014 P804A P805A tiling clone,   3014/3014
(100 %)
12 diff
(99.7 %id)
NM_003884.4   KAT2B.a 14 to 4837 1 to 4824 exact RefSeq,   4824/4824
(100 %)
0 diff
(100 %id)
CB991764 placenta, pre-eclamptic placenta KAT2B.a 337 to 753 21 to 439       419/979
(42 %)
18 diff
(98.2 %id)
CB995340 placenta, pre-eclamptic placenta KAT2B.a 337 to 767 21 to 452       432/1260
(34 %)
8 diff
(99.4 %id)
CB991200 placenta, pre-eclamptic placenta KAT2B.a 337 to 1022 21 to 716       696/866
(80 %)
28 diff
(96.8 %id)
BC070075 Placenta, pre-eclamptic KAT2B.a 344 to 4835 1 to 4492 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 4492/4492
(100 %)
1 diff
(100.0 %id)
AL120274 amygdala KAT2B.a 396 to 763 1 to 367       367/392
(93 %)
2 diff
(99.5 %id)
DR005543 Prostate KAT2B.a 405 to 1131 1 to 727       727/727
(100 %)
4 diff
(99.5 %id)
BC060823 Placenta, pre-eclamptic KAT2B.a 409 to 4835 1 to 4427 exact available from MGC, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 4427/4427
(100 %)
1 diff
(100.0 %id)
DR002323 fetal brain KAT2B.a 440 to 1243 9 to 806       798/900
(88 %)
15 diff
(98.4 %id)
BI792093 Pancreas, Purified pancreatic islet KAT2B.a 567 to 1211 1 to 646       646/647
(99 %)
12 diff
(98.2 %id)
CD110212 placenta, pre-eclamptic placenta KAT2B.a 606 to 1113 28 to 548       520/749
(69 %)
35 diff
(95.4 %id)
CB992771 placenta, pre-eclamptic placenta KAT2B.a 606 to 1312 28 to 734       707/818
(86 %)
11 diff
(98.7 %id)
CK820818 Pancreas, Purified pancreatic islet KAT2B.a 607 to 1212 1 to 606     Submitted on the opposite strand 606/606
(100 %)
1 diff
(99.9 %id)
BI600608 brain, hypothalamus KAT2B.a 788 to 1542 1 to 757       757/766
(98 %)
13 diff
(98.4 %id)
TI_45210590   KAT2B.a 791 to 1542 88 to 841       754/850
(88 %)
14 diff
(98.4 %id)
DA235937 brain KAT2B.a 850 to 1418 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CT003947 T-Lymphocytes KAT2B.a 856 to 1718 1 to 863       863/868
(99 %)
4 diff
(99.6 %id)
BX496729 Liver KAT2B.a 868 to 1452 1 to 585       585/585
(100 %)
2 diff
(99.7 %id)
BE540370 cervix KAT2B.a 888 to 1502 13 to 635       623/887
(70 %)
27 diff
(97.0 %id)
BX495786 Liver KAT2B.a 994 to 1496 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
TI_154153676   KAT2B.a 1002 to 1615 81 to 694       614/614
(100 %)
1 diff
(99.9 %id)
BU431718 lymph KAT2B.a 1024 to 1595 31 to 601       571/601
(95 %)
6 diff
(99.1 %id)
BM546102 ovary (pool of 3) KAT2B.a 1127 to 2085 18 to 972       955/1124
(84 %)
23 diff
(98.0 %id)
CA395463 eye, RPE/choroid KAT2B.a 1187 to 1720 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BF574240 muscle (skeletal) KAT2B.a 1232 to 1876 1 to 647       647/825
(78 %)
16 diff
(98.1 %id)
BX497678 Liver KAT2B.a 1248 to 1784 1 to 537       537/537
(100 %)
15 diff
(97.3 %id)
DA237070 brain KAT2B.a 1301 to 1894 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
BQ379302 uterus_tumor KAT2B.a 1441 to 2101 17 to 673       657/674
(97 %)
15 diff
(97.8 %id)
BU154737 melanotic melanoma, skin KAT2B.a 1450 to 2328 1 to 880       880/901
(97 %)
18 diff
(98.1 %id)
DA351206 substantia nigra KAT2B.a 1505 to 2101 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
CD638815 pooled KAT2B.a 1523 to 2170 1 to 645       645/645
(100 %)
5 diff
(99.3 %id)
T91419 liver and spleen KAT2B.a 1552 to 1817 1 to 266   fully sequenced,   266/266
(100 %)
1 diff
(99.7 %id)
DA949479 Spleen KAT2B.a 1597 to 2142 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
T85097 liver and spleen KAT2B.a 1608 to 2064 490 to 21       470/494
(95 %)
12 diff
(97.6 %id)
R98806 liver and spleen KAT2B.a 1610 to 2073 471 to 1       471/474
(99 %)
9 diff
(98.2 %id)
AL135389 melanoma (MeWo cell line) KAT2B.a 1640 to 2245 1 to 605       605/605
(100 %)
1 diff
(99.9 %id)
H62591 liver and spleen KAT2B.a 1700 to 2066 373 to 1     Submitted on the opposite strand 373/376
(99 %)
8 diff
(97.9 %id)
BE930035 placenta_normal KAT2B.a 1734 to 2083 367 to 18       352/376
(93 %)
1 diff
(99.8 %id)
T91333 liver and spleen KAT2B.a 1787 to 2048 264 to 1   fully sequenced,   264/264
(100 %)
0 diff
(100 %id)
DN912431   KAT2B.a 1901 to 2415 1 to 515       515/515
(100 %)
2 diff
(99.7 %id)
BG742043 skin KAT2B.a 1939 to 2677 1 to 748       748/790
(94 %)
33 diff
(95.9 %id)
T07150   KAT2B.a 1944 to 2191 1 to 248       248/248
(100 %)
0 diff
(100 %id)
BF888572 testis_normal KAT2B.a 1990 to 2082 104 to 14     Submitted on the opposite strand 91/104
(87 %)
0 diff
(100 %id)
BP424719 small intestine KAT2B.a 2083 to 2578 13 to 509     Submitted on the opposite strand 497/509
(97 %)
6 diff
(98.9 %id)
AL832173 human cervix KAT2B.a 2101 to 4835 1 to 2735   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 2735/2736
(99 %)
2 diff
(100.0 %id)
N39522 liver and spleen KAT2B.a 2119 to 2732 1 to 618     Submitted on the opposite strand 618/619
(99 %)
12 diff
(98.1 %id)
N74637 liver and spleen KAT2B.a 2125 to 2387 1 to 263     Submitted on the opposite strand 263/263
(100 %)
0 diff
(100 %id)
H38810 liver and spleen KAT2B.a 2126 to 2454 1 to 331     Submitted on the opposite strand 331/342
(96 %)
9 diff
(97.4 %id)
H48536 liver and spleen KAT2B.a 2143 to 2483 1 to 347     Submitted on the opposite strand 347/347
(100 %)
6 diff
(98.3 %id)
BF964137 nervous_normal KAT2B.a 2199 to 2608 424 to 15       410/424
(96 %)
5 diff
(98.9 %id)
BF959994 nervous_normal KAT2B.a 2201 to 2608 1 to 413       413/428
(96 %)
16 diff
(96.3 %id)
BF959507 nervous_normal KAT2B.a 2206 to 2593 7 to 394       388/394
(98 %)
6 diff
(98.5 %id)
BF963444 nervous_normal KAT2B.a 2208 to 2608 1 to 401       401/416
(96 %)
5 diff
(98.8 %id)
BU171918 melanotic melanoma, skin KAT2B.a 2222 to 3117 1 to 903       903/905
(99 %)
14 diff
(98.5 %id)
BF954199 nervous_normal KAT2B.a 2231 to 2608 1 to 376       376/391
(96 %)
5 diff
(98.8 %id)
AA054180 eye, retina KAT2B.a 2263 to 2720 1 to 462       462/462
(100 %)
5 diff
(99.0 %id)
AI337108 pooled germ cell tumors KAT2B.a 2296 to 2954 664 to 8   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 657/664
(98 %)
13 diff
(98.1 %id)
BE550575 pooled germ cell tumors KAT2B.a 2317 to 2954 645 to 8   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 638/654
(97 %)
1 diff
(99.9 %id)
BX494408 Liver KAT2B.a 2396 to 2589 1 to 195       195/195
(100 %)
2 diff
(99.0 %id)
AV746714 Pituitary KAT2B.a 2406 to 2929 1 to 509       509/542
(93 %)
19 diff
(96.5 %id)
DA274763 corpus callosum KAT2B.a 2430 to 2976 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
BI713688 Pancreas, Purified pancreatic islet KAT2B.a 2449 to 3086 638 to 1       638/638
(100 %)
4 diff
(99.4 %id)
BP326742 prostata KAT2B.a 2509 to 3091 1 to 583       583/583
(100 %)
6 diff
(99.0 %id)
DA157972 amygdala KAT2B.a 2585 to 3161 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB480199 hippocampus KAT2B.a 2598 to 3093 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
DA368119 subthalamic nucleus KAT2B.a 2616 to 3194 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CU448957 epidermis KAT2B.a 2621 to 3051 442 to 12     Submitted on the opposite strand 431/451
(95 %)
0 diff
(100 %id)
CU456371 epidermis KAT2B.a 2621 to 3051 442 to 12     Submitted on the opposite strand 431/451
(95 %)
0 diff
(100 %id)
W00975 liver and spleen KAT2B.a 2677 to 2976 303 to 1     Submitted on the opposite strand 303/335
(90 %)
3 diff
(99.2 %id)
R27509 placenta KAT2B.a 2679 to 3001 1 to 333       333/333
(100 %)
17 diff
(94.9 %id)
BP334361 salivary gland KAT2B.a 2689 to 3275 1 to 584       584/584
(100 %)
6 diff
(99.0 %id)
AA348381 brain, hippocampus KAT2B.a 2781 to 3086 1 to 306       306/307
(99 %)
1 diff
(99.7 %id)
AW950760   KAT2B.a 2781 to 3427 1 to 644       644/644
(100 %)
13 diff
(98.0 %id)
DN912430   KAT2B.a 2841 to 2969 129 to 1       129/129
(100 %)
0 diff
(100 %id)
DA385052 thalamus KAT2B.a 2847 to 3417 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
BG708174 brain, hypothalamus KAT2B.a 2877 to 3598 1 to 717       717/718
(99 %)
7 diff
(99.1 %id)
BI458362 brain, hypothalamus KAT2B.a 2877 to 3646 1 to 771       771/772
(99 %)
11 diff
(98.6 %id)
DB484967 hypothalamus KAT2B.a 2882 to 3329 1 to 448       448/448
(100 %)
3 diff
(99.4 %id)
DB500917 hypothalamus KAT2B.a 2882 to 3361 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
DB504343 hypothalamus KAT2B.a 2882 to 3356 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
BF977811 melanotic melanoma, high MDR, skin KAT2B.a 2931 to 3644 1 to 697       697/870
(80 %)
17 diff
(98.1 %id)
BX487436   KAT2B.a 3032 to 3555 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
BQ722211 sympathetic trunk KAT2B.a 3114 to 4007 48 to 953       906/989
(91 %)
19 diff
(98.1 %id)
H38890 liver and spleen KAT2B.a 3129 to 3560 435 to 1     Submitted on the opposite strand 435/435
(100 %)
10 diff
(97.8 %id)
AA054135 eye, retina KAT2B.a 4462 to 4832 376 to 1       376/395
(95 %)
10 diff
(97.5 %id)
R25657 placenta KAT2B.a 4700 to 4834 135 to 1       135/135
(100 %)
3 diff
(97.8 %id)
AW578428 colon KAT2B.b 1 to 590 2 to 591   tiling clone,   590/591
(99 %)
27 diff
(95.5 %id)
AW604367 colon KAT2B.b 1 to 590 2 to 591       590/591
(99 %)
27 diff
(95.5 %id)
BF092761 testis_normal KAT2B.b 167 to 782 1 to 615       615/640
(96 %)
3 diff
(99.6 %id)
DB146779 thymus KAT2B.b 170 to 737 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BF092685 testis_normal KAT2B.b 180 to 785 1 to 605       605/650
(93 %)
9 diff
(98.7 %id)
N75694 nose, olfactory epithelium KAT2B.b 660 to 993 10 to 344   tiling clone,   335/344
(97 %)
6 diff
(98.3 %id)
CB046099 2 pooled tumors (clear cell type), Kidney KAT2B.b 759 to 1463 1 to 705   tiling clone, Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 705/705
(100 %)
4 diff
(99.5 %id)
AA411649 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.b 1302 to 1675 1 to 374   fully sequenced,   374/374
(100 %)
1 diff
(99.8 %id)
BX104740 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.b 1303 to 1987 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
AA195591 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.b 1317 to 1717 1 to 407   tiling clone, fully sequenced,   407/407
(100 %)
9 diff
(97.8 %id)
AI276138 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.b 1537 to 2026 490 to 1   tiling clone,   490/490
(100 %)
1 diff
(99.8 %id)
AI042194 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.b 1621 to 2026 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AA411650 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.b 1645 to 2026 382 to 1   fully sequenced,   382/382
(100 %)
1 diff
(99.8 %id)
AA194887 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.b 1687 to 2027 344 to 1   fully sequenced,   344/344
(100 %)
4 diff
(98.9 %id)
CB046098 2 pooled tumors (clear cell type), Kidney KAT2B.b 1819 to 2472 680 to 27   tiling clone, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 654/654
(100 %)
2 diff
(99.7 %id)
TI_149289411   KAT2B.b 1844 to 2472 728 to 103   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 626/629
(99 %)
9 diff
(98.6 %id)
BM970968 lung KAT2B.b 1937 to 2490 553 to 1       553/553
(100 %)
2 diff
(99.7 %id)
DB569622 hypothalamus KAT2B.b 1941 to 2472 1 to 532     Submitted on the opposite strand 532/532
(100 %)
5 diff
(99.1 %id)
DB565039 hypothalamus KAT2B.b 2016 to 2472 1 to 457     Submitted on the opposite strand 457/457
(100 %)
4 diff
(99.2 %id)
DB568283 hypothalamus KAT2B.b 2021 to 2472 1 to 452     Submitted on the opposite strand 452/452
(100 %)
5 diff
(98.9 %id)
BX089312 aorta KAT2B.b 2024 to 2472 1 to 450   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 450/450
(100 %)
5 diff
(98.9 %id)
AI735446 aorta KAT2B.b 2063 to 2474 412 to 1       412/412
(100 %)
7 diff
(98.4 %id)
AI735438 aorta KAT2B.b 2063 to 2471 420 to 12   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 409/409
(100 %)
3 diff
(99.3 %id)
N27321 nose, olfactory epithelium KAT2B.b 2065 to 2494 433 to 1       433/433
(100 %)
7 diff
(98.4 %id)
AA766914 germinal center B cell KAT2B.b 2078 to 2493 416 to 1   tiling clone,   416/416
(100 %)
0 diff
(100 %id)
AV735100 pheochromocytoma KAT2B.b 2110 to 2493 1 to 385       385/578
(66 %)
7 diff
(98.8 %id)
DB071393 testis KAT2B.b 2482 to 3016 2 to 536   tiling clone, capped   535/535
(100 %)
2 diff
(99.7 %id)
BU658393 blood KAT2B.c 1 to 392 14 to 405   tiling clone,   394/405
(97 %)
8 diff
(98.1 %id)
AA743618 germinal center B cell KAT2B.c 307 to 774 1 to 467   tiling clone,   467/467
(100 %)
4 diff
(99.2 %id)
TI_153993157   KAT2B.c 545 to 1050 600 to 96   tiling clone,   505/600
(84 %)
0 diff
(100 %id)
DA939597 Spleen KAT2B.d 1 to 592 2 to 594 F56X K57* tiling clone, capped   593/594
(99 %)
2 diff
(99.7 %id)
DB144501 thymus KAT2B.d 332 to 876 2 to 551   tiling clone, capped   550/550
(100 %)
7 diff
(98.8 %id)
AV759458 bone marrow KAT2B.e 1 to 493 1 to 493   tiling clone,   493/509
(96 %)
3 diff
(99.5 %id)
DA234403 brain KAT2B.e 24 to 609 2 to 587 exact tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
DA115236 cerebellum KAT2B.f-u 1 to 487 2 to 488   tiling clone, to resequence, capped   487/487
(100 %)
0 diff
(100 %id)
DA398468 thalamus KAT2B.f-u 130 to 701 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
DB228708 trachea KAT2B.f-u 233 to 830 2 to 599   tiling clone, capped   598/598
(100 %)
1 diff
(99.9 %id)
DB231323 trachea KAT2B.f-u 233 to 794 2 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
DB131237 thymus KAT2B.f-u 583 to 1114 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
DB112247 thymus KAT2B.f-u 625 to 1202 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
BQ636775 eye, retina KAT2B.f-u 762 to 1300 1 to 539   tiling clone,   539/539
(100 %)
0 diff
(100 %id)
DA305926 hippocampus KAT2B.f-u 1128 to 1718 2 to 592   tiling clone, capped   591/591
(100 %)
1 diff
(99.9 %id)
AV654571 corresponding non cancerous liver tissue KAT2B.f-u 1371 to 2042 1 to 671 S50Q K51* tiling clone, Submitted on the opposite strand 671/673
(99 %)
12 diff
(98.3 %id)
BU198229   KAT2B.f-u 2091 to 2655 1 to 563   tiling clone,   563/564
(99 %)
16 diff
(97.2 %id)
CN281349 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells KAT2B.f-u 2116 to 2733 1 to 618   tiling clone,   618/618
(100 %)
1 diff
(99.9 %id)
DA357978 subthalamic nucleus KAT2B.f-u 2121 to 2685 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BG498546 adenocarcinoma, Prostate KAT2B.f-u 2279 to 2984 1 to 731       731/732
(99 %)
38 diff
(94.9 %id)
BM466071 embryonal carcinoma, cell line, testis KAT2B.f-u 2284 to 3260 1 to 983   AAA   983/1076
(91 %)
21 diff
(98.1 %id)
BQ882961 sympathetic trunk KAT2B.f-u 2328 to 2916 1 to 593       593/1001
(59 %)
20 diff
(98.1 %id)
CB956744 Pooled-Glandular KAT2B.f-u 2349 to 3146 1 to 802       802/806
(99 %)
14 diff
(98.3 %id)
N45344 liver and spleen KAT2B.f-u 2374 to 2513 140 to 1     Submitted on the opposite strand 140/140
(100 %)
0 diff
(100 %id)
DN912387   KAT2B.f-u 2400 to 2816 1 to 417       417/417
(100 %)
2 diff
(99.6 %id)
AW298563   KAT2B.f-u 2401 to 2905 522 to 18   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 505/505
(100 %)
0 diff
(100 %id)
BE815387 breast_normal KAT2B.f-u 2425 to 2781 15 to 371       357/371
(96 %)
6 diff
(98.4 %id)
AW662964 2 pooled high-grade transitional celltumors, genitourinary tract KAT2B.f-u 2470 to 2797 1 to 328       328/329
(99 %)
1 diff
(99.7 %id)
BG026381 Bone, osteosarcoma, cell line KAT2B.f-u 2539 to 3265 1 to 732       732/880
(83 %)
12 diff
(98.7 %id)
CB147681 Liver KAT2B.f-u 2592 to 3162 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
CD520353 pooled KAT2B.f-u 2630 to 3265 1 to 638       638/778
(82 %)
12 diff
(98.5 %id)
BM721529 eye, fetal eye KAT2B.f-u 2633 to 3064 1 to 432     Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 432/432
(100 %)
0 diff
(100 %id)
H13111 placenta KAT2B.f-u 2662 to 3014 1 to 358       358/360
(99 %)
7 diff
(98.1 %id)
CB963231 Blood vessels - aorta, basilar and artery KAT2B.f-u 2698 to 3415 1 to 723   tiling clone,   723/793
(91 %)
13 diff
(98.4 %id)
AL121054 melanoma (MeWo cell line) KAT2B.f-u 2712 to 3108 1 to 397       397/397
(100 %)
1 diff
(99.8 %id)
BF789936 muscle (skeletal) KAT2B.f-u 2747 to 3434 1 to 676       676/833
(81 %)
30 diff
(96.4 %id)
CB998981 Pooled-Skin KAT2B.f-u 2769 to 3282 1 to 521       521/1122
(46 %)
18 diff
(98.4 %id)
AA311685 heart KAT2B.f-u 2775 to 3066 1 to 296       296/296
(100 %)
5 diff
(98.4 %id)
BQ332887 lung_tumor KAT2B.f-u 2791 to 3147 405 to 47       359/405
(88 %)
0 diff
(100 %id)
CV572610 cornea, eye KAT2B.f-u 2809 to 3450 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
W06872 lung KAT2B.f-u 2816 to 3415 1 to 612       612/613
(99 %)
17 diff
(97.3 %id)
CD110715 Blood vessels - aorta, basilar and artery KAT2B.f-u 2852 to 3496 1 to 654       654/739
(88 %)
18 diff
(97.6 %id)
TI_149278945   KAT2B.f-u 2907 to 3785 960 to 89   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 872/1050
(83 %)
12 diff
(98.9 %id)
TI_149286917   KAT2B.f-u 2908 to 3784 936 to 61   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 876/1185
(73 %)
21 diff
(98.3 %id)
BF029654 bladder, carcinoma, cell line KAT2B.f-u 2940 to 3610 1 to 684       684/1088
(62 %)
45 diff
(95.9 %id)
BE568279 bladder, carcinoma, cell line KAT2B.f-u 2941 to 3599 1 to 650       650/652
(99 %)
22 diff
(96.7 %id)
BF029043 bladder, carcinoma, cell line KAT2B.f-u 2941 to 3526 1 to 594       594/858
(69 %)
28 diff
(96.8 %id)
FN138497 breast carcinoma KAT2B.f-u 2965 to 3071 106 to 1     Submitted on the opposite strand 106/106
(100 %)
3 diff
(97.2 %id)
BF086764 placenta_normal KAT2B.f-u 2973 to 3163 190 to 1       190/197
(96 %)
8 diff
(96.0 %id)
BQ369988 placenta_normal KAT2B.f-u 2973 to 3157 195 to 9       187/203
(92 %)
0 diff
(100 %id)
BF086777 placenta_normal KAT2B.f-u 2975 to 3175 1 to 198       198/198
(100 %)
3 diff
(98.5 %id)
BF985979 placenta_normal KAT2B.f-u 2975 to 3175 1 to 195       195/195
(100 %)
8 diff
(95.9 %id)
BF985991 placenta_normal KAT2B.f-u 2975 to 3175 1 to 201       201/201
(100 %)
3 diff
(98.6 %id)
CV324964 placenta_normal KAT2B.f-u 2975 to 3181 207 to 1     Submitted on the opposite strand 207/211
(98 %)
17 diff
(92.0 %id)
BQ370250 placenta_normal KAT2B.f-u 2977 to 3142 168 to 1       168/168
(100 %)
8 diff
(95.3 %id)
BF086770 placenta_normal KAT2B.f-u 2978 to 3175 1 to 196       196/196
(100 %)
4 diff
(98.0 %id)
BF086753 placenta_normal KAT2B.f-u 2983 to 3175 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
BF086759 placenta_normal KAT2B.f-u 2983 to 3166 200 to 19       182/200
(91 %)
0 diff
(100 %id)
BF086760 placenta_normal KAT2B.f-u 2983 to 3181 206 to 10       197/206
(95 %)
0 diff
(100 %id)
BF086761 placenta_normal KAT2B.f-u 2983 to 3179 196 to 1       196/196
(100 %)
7 diff
(96.5 %id)
BF086765 placenta_normal KAT2B.f-u 2983 to 3181 204 to 8       197/204
(96 %)
0 diff
(100 %id)
BF086768 placenta_normal KAT2B.f-u 2983 to 3156 199 to 28       172/199
(86 %)
0 diff
(100 %id)
BF086769 placenta_normal KAT2B.f-u 2983 to 3181 207 to 11       197/207
(95 %)
0 diff
(100 %id)
BF086771 placenta_normal KAT2B.f-u 2983 to 3160 195 to 18       178/195
(91 %)
0 diff
(100 %id)
BF086781 placenta_normal KAT2B.f-u 2983 to 3159 182 to 6       177/182
(97 %)
0 diff
(100 %id)
BF369345 placenta_normal KAT2B.f-u 2983 to 3175 193 to 1       193/193
(100 %)
3 diff
(98.5 %id)
BF985984 placenta_normal KAT2B.f-u 2983 to 3166 183 to 1       183/183
(100 %)
2 diff
(99.0 %id)
BF985986 placenta_normal KAT2B.f-u 2983 to 3182 203 to 6       198/203
(97 %)
0 diff
(100 %id)
BF985987 placenta_normal KAT2B.f-u 2983 to 3165 185 to 3       183/185
(98 %)
0 diff
(100 %id)
BF985988 placenta_normal KAT2B.f-u 2983 to 3137 1 to 155       155/155
(100 %)
1 diff
(99.4 %id)
BQ370251 placenta_normal KAT2B.f-u 2983 to 3178 213 to 18       196/213
(92 %)
0 diff
(100 %id)
CV324965 placenta_normal KAT2B.f-u 2983 to 3176 193 to 1     Submitted on the opposite strand 193/193
(100 %)
15 diff
(92.3 %id)
BF086756 placenta_normal KAT2B.f-u 2985 to 3157 175 to 2       174/177
(98 %)
0 diff
(100 %id)
BF086772 placenta_normal KAT2B.f-u 2985 to 3175 1 to 190       190/190
(100 %)
4 diff
(97.9 %id)
BF086774 placenta_normal KAT2B.f-u 2985 to 3157 179 to 7       173/179
(96 %)
0 diff
(100 %id)
BF922445 nervous_tumor KAT2B.f-u 2986 to 3294 315 to 6     Submitted on the opposite strand 310/325
(95 %)
0 diff
(100 %id)
BF922778 nervous_tumor KAT2B.f-u 2986 to 3294 314 to 5     Submitted on the opposite strand 310/324
(95 %)
0 diff
(100 %id)
BF922782 nervous_tumor KAT2B.f-u 2986 to 3233 10 to 257       248/257
(96 %)
6 diff
(97.7 %id)
BF922783 nervous_tumor KAT2B.f-u 2986 to 3103 122 to 4     Submitted on the opposite strand 119/132
(90 %)
0 diff
(100 %id)
BF924048 nervous_tumor KAT2B.f-u 2986 to 3294 315 to 7     Submitted on the opposite strand 309/325
(95 %)
0 diff
(100 %id)
BF924049 nervous_tumor KAT2B.f-u 2986 to 3294 314 to 5     Submitted on the opposite strand 310/338
(91 %)
0 diff
(100 %id)
BF924051 nervous_tumor KAT2B.f-u 2986 to 3294 314 to 6     Submitted on the opposite strand 309/324
(95 %)
0 diff
(100 %id)
BF924054 nervous_tumor KAT2B.f-u 2986 to 3294 11 to 320       310/326
(95 %)
4 diff
(98.8 %id)
BF924057 nervous_tumor KAT2B.f-u 2986 to 3294 316 to 7     Submitted on the opposite strand 310/340
(91 %)
0 diff
(100 %id)
BF922937 nervous_tumor KAT2B.f-u 2987 to 3294 314 to 5     Submitted on the opposite strand 310/326
(95 %)
0 diff
(100 %id)
BF985980 placenta_normal KAT2B.f-u 2993 to 3175 1 to 181       181/181
(100 %)
3 diff
(98.4 %id)
BQ346981 nervous_tumor KAT2B.f-u 2993 to 3294 15 to 316       302/322
(93 %)
10 diff
(96.9 %id)
BF086779 placenta_normal KAT2B.f-u 2994 to 3175 1 to 182       182/182
(100 %)
2 diff
(99.0 %id)
BF985983 placenta_normal KAT2B.f-u 2994 to 3175 1 to 182       182/182
(100 %)
1 diff
(99.5 %id)
BF985990 placenta_normal KAT2B.f-u 2994 to 3175 1 to 182       182/182
(100 %)
2 diff
(99.0 %id)
BF086766 placenta_normal KAT2B.f-u 2996 to 3175 1 to 180       180/180
(100 %)
2 diff
(98.9 %id)
BF086780 placenta_normal KAT2B.f-u 2996 to 3175 2 to 181       180/181
(99 %)
5 diff
(97.3 %id)
BF985989 placenta_normal KAT2B.f-u 2996 to 3175 1 to 179       179/179
(100 %)
2 diff
(98.9 %id)
BF086758 placenta_normal KAT2B.f-u 2997 to 3175 1 to 178       178/178
(100 %)
7 diff
(96.1 %id)
BF086754 placenta_normal KAT2B.f-u 2999 to 3175 1 to 177       177/177
(100 %)
5 diff
(97.2 %id)
BF086757 placenta_normal KAT2B.f-u 3002 to 3175 1 to 171       171/171
(100 %)
6 diff
(96.5 %id)
BF086752 placenta_normal KAT2B.f-u 3005 to 3175 41 to 211       171/211
(81 %)
6 diff
(97.2 %id)
BM789942 stomach KAT2B.f-u 3005 to 3608 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
BF086755 placenta_normal KAT2B.f-u 3006 to 3175 10 to 178       169/178
(94 %)
6 diff
(96.7 %id)
BF985978 placenta_normal KAT2B.f-u 3011 to 3175 9 to 173       165/173
(95 %)
6 diff
(96.6 %id)
BF369359 placenta_normal KAT2B.f-u 3015 to 3175 161 to 1       161/161
(100 %)
1 diff
(99.4 %id)
AW021507.
matches multiple genes
cochlea, ear KAT2B.f-u 3021 to 3543 8 to 530     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base), also hits gene KPNA5 523/530
(98 %)
6 diff
(98.9 %id)
BF086776 placenta_normal KAT2B.f-u 3026 to 3175 1 to 151       151/151
(100 %)
4 diff
(97.4 %id)
CR592587 thymus KAT2B.f-u 3028 to 3785 1 to 758       758/758
(100 %)
0 diff
(100 %id)
BX415882 thymus KAT2B.f-u 3028 to 3785 1 to 758   fully sequenced,   758/758
(100 %)
1 diff
(99.9 %id)
N54020 multiple sclerosis lesions KAT2B.f-u 3038 to 3191 1 to 155       155/155
(100 %)
1 diff
(99.4 %id)
BE093780 breast KAT2B.f-u 3043 to 3347 305 to 1     Submitted on the opposite strand 305/305
(100 %)
0 diff
(100 %id)
BQ006446 Chondrosarcoma, Left Pelvis KAT2B.f-u 3048 to 3784 755 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 737/740
(99 %)
1 diff
(99.9 %id)
BF369368 placenta_normal KAT2B.f-u 3054 to 3189 1 to 138       138/147
(93 %)
8 diff
(94.6 %id)
CD723514 eye, lacrimal gland KAT2B.f-u 3071 to 3700 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
CD250449 Blood vessels - aorta, basilar and artery KAT2B.f-u 3085 to 3735 1 to 663       663/816
(81 %)
31 diff
(96.3 %id)
TI_154113065   KAT2B.f-u 3109 to 3785 764 to 96   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 669/899
(74 %)
28 diff
(96.9 %id)
TI_149290303   KAT2B.f-u 3114 to 3784 811 to 142   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 670/819
(81 %)
34 diff
(95.9 %id)
TI_151808762   KAT2B.f-u 3116 to 3681 75 to 640   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 566/566
(100 %)
1 diff
(99.9 %id)
BM754801 Ascites, stomach KAT2B.f-u 3131 to 3610 1 to 479       479/479
(100 %)
8 diff
(98.4 %id)
BM972326 lung KAT2B.f-u 3133 to 3784 670 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 652/652
(100 %)
3 diff
(99.6 %id)
BQ003704 Chondrosarcoma, Left Pelvis KAT2B.f-u 3134 to 3784 669 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 651/651
(100 %)
0 diff
(100 %id)
BU678653 lung, Primary Lung Epithelial Cells KAT2B.f-u 3141 to 3785 663 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
FN106391 breast carcinoma KAT2B.f-u 3183 to 3250 68 to 1     Submitted on the opposite strand 68/69
(98 %)
0 diff
(100 %id)
BI492467.
matches multiple genes
cochlea, ear KAT2B.f-u 3194 to 3785 625 to 34   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base), also hits gene DOK6 592/592
(100 %)
13 diff
(97.9 %id)
DN912386   KAT2B.f-u 3213 to 3698 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
H84617 eye, retina KAT2B.f-u 3220 to 3606 1 to 390       390/391
(99 %)
7 diff
(98.3 %id)
R81397 placenta KAT2B.f-u 3228 to 3472 1 to 249       249/249
(100 %)
4 diff
(98.4 %id)
BQ184954 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid KAT2B.f-u 3234 to 3678 465 to 21       445/465
(95 %)
0 diff
(100 %id)
AW192906 adenocarcinoma, Pancreas KAT2B.f-u 3242 to 3784 543 to 1       543/543
(100 %)
0 diff
(100 %id)
R24493 placenta KAT2B.f-u 3251 to 3658 1 to 417       417/451
(92 %)
13 diff
(97.2 %id)
DB310521 subthalamic nucleus KAT2B.f-u 3273 to 3785 516 to 1       516/516
(100 %)
3 diff
(99.5 %id)
BP397575 pancreatic islet KAT2B.f-u 3286 to 3785 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP397542 pancreatic islet KAT2B.f-u 3287 to 3787 1 to 501   tiling clone, Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
BF435482 sciatic nerve KAT2B.f-u 3298 to 3787 490 to 1       490/490
(100 %)
2 diff
(99.6 %id)
DB575585 hypothalamus KAT2B.f-u 3301 to 3782 1 to 482     Submitted on the opposite strand 482/484
(99 %)
1 diff
(99.8 %id)
AI470039 pooled KAT2B.f-u 3307 to 3710 434 to 31   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 404/404
(100 %)
6 diff
(98.6 %id)
AW055129 brain, glioblastoma (pooled) KAT2B.f-u 3307 to 3782 477 to 1       477/477
(100 %)
3 diff
(99.4 %id)
AI814127 normal prostate, Prostate KAT2B.f-u 3310 to 3787 482 to 5       478/482
(99 %)
0 diff
(100 %id)
AA741321 germinal center B cell KAT2B.f-u 3312 to 3787 481 to 6       476/481
(98 %)
0 diff
(100 %id)
DB572100 hypothalamus KAT2B.f-u 3318 to 3782 1 to 465     Submitted on the opposite strand 465/467
(99 %)
1 diff
(99.8 %id)
DB552483 hippocampus KAT2B.f-u 3320 to 3785 1 to 466     Submitted on the opposite strand 466/466
(100 %)
0 diff
(100 %id)
BF196582 brain, glioblastoma (pooled) KAT2B.f-u 3324 to 3774 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI628415 Kidney KAT2B.f-u 3327 to 3774 466 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 448/448
(100 %)
1 diff
(99.8 %id)
AW026794 poorly differentiated adenocarcinoma withsignet ring cell features, stomach KAT2B.f-u 3327 to 3782 456 to 1       456/456
(100 %)
0 diff
(100 %id)
BU681764 lung KAT2B.f-u 3333 to 3784 470 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 452/452
(100 %)
1 diff
(99.8 %id)
BM677158 eye, fetal eye KAT2B.f-u 3334 to 3782 468 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 450/450
(100 %)
1 diff
(99.8 %id)
AA443250.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus KAT2B.f-u 3338 to 3720 1 to 384     also hits gene METTL10andFAM53B 384/384
(100 %)
2 diff
(99.5 %id)
AW295619   KAT2B.f-u 3339 to 3784 463 to 18   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 446/446
(100 %)
1 diff
(99.8 %id)
BM680886 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid KAT2B.f-u 3343 to 3747 44 to 448   AAA Submitted on the opposite strand 405/448
(90 %)
6 diff
(98.7 %id)
BM726280 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid KAT2B.f-u 3343 to 3787 490 to 46     Submitted on the opposite strand 445/516
(86 %)
0 diff
(100 %id)
DB547243 hippocampus KAT2B.f-u 3347 to 3785 1 to 439     Submitted on the opposite strand 439/439
(100 %)
0 diff
(100 %id)
AW051871 brain, glioblastoma (pooled) KAT2B.f-u 3349 to 3785 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AW015856   KAT2B.f-u 3352 to 3775 448 to 25   AAA   424/431
(98 %)
0 diff
(100 %id)
DB554059 hypothalamus KAT2B.f-u 3362 to 3782 1 to 423     Submitted on the opposite strand 423/425
(99 %)
3 diff
(99.3 %id)
DB548940 hippocampus KAT2B.f-u 3363 to 3782 1 to 420   AAA Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
AA700510 parathyroid gland, parathyroid tumor KAT2B.f-u 3377 to 3783 426 to 20       407/426
(95 %)
0 diff
(100 %id)
AW971394   KAT2B.f-u 3381 to 3793 522 to 110     Submitted on the opposite strand 413/537
(76 %)
5 diff
(99.1 %id)
AA507222 Prostate KAT2B.f-u 3381 to 3784 406 to 1       406/410
(99 %)
2 diff
(99.6 %id)
DB300141 cerebellum KAT2B.f-u 3384 to 3782 399 to 1   to resequence,   399/404
(98 %)
2 diff
(99.6 %id)
AW103705 brain, tumor, 5 pooled (see description) KAT2B.f-u 3385 to 3787 406 to 4       403/410
(98 %)
0 diff
(100 %id)
AI494174 Kidney KAT2B.f-u 3388 to 3784 398 to 2     Submitted on the opposite strand 397/398
(99 %)
0 diff
(100 %id)
BQ005370 Chondrosarcoma, Left Pelvis KAT2B.f-u 3390 to 3784 413 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 395/395
(100 %)
12 diff
(97.0 %id)
AA643963 adrenal adenoma, adrenal gland KAT2B.f-u 3399 to 3743 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AI418217 brain, glioblastoma (pooled) KAT2B.f-u 3402 to 3787 387 to 1       387/387
(100 %)
1 diff
(99.8 %id)
AI359336 brain, glioblastoma (pooled) KAT2B.f-u 3406 to 3787 385 to 4       382/385
(99 %)
0 diff
(100 %id)
AA668345   KAT2B.f-u 3412 to 3782 384 to 15   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 370/370
(100 %)
1 diff
(99.8 %id)
AI359344 brain, glioblastoma (pooled) KAT2B.f-u 3413 to 3787 382 to 8       375/382
(98 %)
0 diff
(100 %id)
AI055899 parathyroid gland, parathyroid tumor KAT2B.f-u 3415 to 3783 380 to 13   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 368/368
(100 %)
1 diff
(99.8 %id)
AI349104 2 pooled tumors (clear cell type), Kidney KAT2B.f-u 3415 to 3787 374 to 2       373/374
(99 %)
0 diff
(100 %id)
AI749010 aorta KAT2B.f-u 3418 to 3774 357 to 1       357/357
(100 %)
0 diff
(100 %id)
CA448582 Chondrosarcoma, Left Pelvis KAT2B.f-u 3421 to 3785 383 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 365/365
(100 %)
0 diff
(100 %id)
D62217   KAT2B.f-u 3426 to 3771 1 to 345       345/345
(100 %)
3 diff
(99.2 %id)
D62219   KAT2B.f-u 3426 to 3771 1 to 345       345/345
(100 %)
3 diff
(99.2 %id)
D62220   KAT2B.f-u 3426 to 3771 1 to 345       345/345
(100 %)
3 diff
(99.2 %id)
D79509 aorta KAT2B.f-u 3426 to 3713 1 to 285       285/285
(100 %)
5 diff
(98.3 %id)
AV727449 hypothalamus KAT2B.f-u 3429 to 3786 1 to 358       358/894
(40 %)
8 diff
(99.2 %id)
AI095559 uterus KAT2B.f-u 3433 to 3787 356 to 2       355/356
(99 %)
0 diff
(100 %id)
AA932428 2 pooled tumors (clear cell type), Kidney KAT2B.f-u 3441 to 3782 358 to 17   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 342/342
(100 %)
0 diff
(100 %id)
AA995793 2 pooled tumors (clear cell type), Kidney KAT2B.f-u 3442 to 3785 356 to 13   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 344/344
(100 %)
1 diff
(99.8 %id)
N70861 lung KAT2B.f-u 3465 to 3782 318 to 1       318/318
(100 %)
2 diff
(99.4 %id)
AI472591 pooled KAT2B.f-u 3492 to 3628 137 to 1       137/137
(100 %)
0 diff
(100 %id)
C00397   KAT2B.f-u 3495 to 3778 1 to 286       286/293
(97 %)
5 diff
(98.3 %id)
AW518786 adenocarcinoma, Pancreas KAT2B.f-u 3558 to 3784 227 to 1       227/237
(95 %)
2 diff
(99.2 %id)
AI470982 brain, glioblastoma (pooled) KAT2B.f-u 3562 to 3774 213 to 1       213/213
(100 %)
0 diff
(100 %id)
AI473523 poorly differentiated adenocarcinoma withsignet ring cell features, stomach KAT2B.f-u 3566 to 3785 230 to 11   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 220/220
(100 %)
0 diff
(100 %id)
FN141399 breast carcinoma KAT2B.f-u 3695 to 3782 90 to 2     Submitted on the opposite strand 89/90
(98 %)
0 diff
(100 %id)
BX415881 thymus KAT2B.f-u 3710 to 3775 65 to 1   fully sequenced,   65/65
(100 %)
0 diff
(100 %id)
DA570967 whole embryo, mainly head KAT2B.g-u 1 to 852 2 to 853   tiling clone, capped   852/852
(100 %)
7 diff
(99.2 %id)
BG745649 Spleen KAT2B.g-u 478 to 877 1 to 418       418/418
(100 %)
18 diff
(95.7 %id)
BM008224 Spleen KAT2B.g-u 478 to 1219 1 to 745   tiling clone,   745/745
(100 %)
9 diff
(98.8 %id)
TI_59382714   KAT2B.g-u 479 to 1219 103 to 846       744/744
(100 %)
8 diff
(99.0 %id)
DB357777 whole embryo, mainly head KAT2B.g-u 979 to 1487 509 to 1   tiling clone,   509/509
(100 %)
5 diff
(99.1 %id)
BX091204 liver and spleen KAT2B.g-u 1476 to 1834 360 to 720   tiling clone,   361/720
(50 %)
6 diff
(99.2 %id)
DA229441 brain KAT2B.g-u 1780 to 2343 2 to 565 R84* tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
H74206.
matches multiple genes
liver and spleen KAT2B.g-u 1900 to 2261 367 to 1   tiling clone, also hits gene goyshaw 367/373
(98 %)
9 diff
(97.6 %id)
BF948837 nervous_normal KAT2B.g-u 2304 to 2725 80 to 504   tiling clone,   425/514
(82 %)
9 diff
(98.3 %id)
BQ720832 sympathetic trunk KAT2B.h-u 1 to 902 1 to 906 exact tiling clone,   906/906
(100 %)
14 diff
(98.5 %id)
DB235853 trachea KAT2B.i 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
DB494005 hypothalamus KAT2B.j-u 1 to 538 1 to 532 F12I F13K I14G K15I G16T ... tiling clone,   532/532
(100 %)
4 diff
(99.3 %id)
DB497233 hypothalamus KAT2B.j-u 1 to 486 1 to 480 F12I F13K I14G K15I G16T ... tiling clone,   480/480
(100 %)
4 diff
(99.2 %id)
DB498555 hypothalamus KAT2B.j-u 1 to 504 1 to 500 F12I F13K I14G K15I G16T ...     500/500
(100 %)
11 diff
(97.8 %id)
DB046625 testis KAT2B.k 1 to 516 2 to 517 exact tiling clone, capped   516/516
(100 %)
0 diff
(100 %id)
DB485435 hypothalamus Gene KAT2B, variant not shown         Suspected internal deletion, this clone was ignored    
AW662143 2 pooled high-grade transitional celltumors, genitourinary tract Gene KAT2B, variant not shown              
CB962765 Blood vessels - aorta, basilar and artery Gene KAT2B, variant not shown       AAA      
DB116224 thymus Gene KAT2B, variant not shown       capped      
DB343669 thymus Gene KAT2B, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h-u, .i, .j-u, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI